Drug Database
Back to search

Netherlands· NL-17dc0fefc47d

Busulfan Eureco-Pharma 6 mg/ml, concentraat voor oplossing voor infusie

A busulfan product containing busulfan, registered in Netherlands by Eureco-Pharma B.V.. The same ATC class is registered in 15 of our 19 countries.

ATC L01AB01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedBusulfan Eureco-Pharma 6 mg/ml, conce…ATCL01AB01REGISTER NO.NL-17dc0fefc47dPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about busulfanAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Busulfan is registered in 15 of 19 countries.

Countries holding a registration under ATC L01AB01 (busulfan), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search busulfan products by name

Busulfan · ATC L01AB01

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
BUSULFAN
Manufacturer
Eureco-Pharma B.V.
Country
Netherlands (NL)
ATC code
L01AB01
ATC class
Busulfan
Defined daily dose
0.224 g, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    133339//120583

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

245 interactions on record for busulfan.

Graded by severity as the source publishes them — 34 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check busulfan against other medicinesHow interaction checks work

Busulfan · interactions on record

245 records

  • 34 severe
  • 141 moderate
  • 16 minor
  • 54 info

Most severe, free to view

  • Nalidixic acidJ01MB02severe
  • MetronidazoleJ01XD01severe
  • ThiotepaL01AC01severe
  • CladribineL01BB04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Busulfan in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All busulfan products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Busulfan Accord, Myleran
  • Belgium · Myleran
  • Czechia · Myleran
  • Germany · Busulfan Accord, Busulfan Koanaa
  • Denmark · Busulfan Zentiva
  • Estonia · Myleran
  • Spain · Busulfano Accord, Busulfano Aspen
  • France · Busulfan Accord, Busulfan Koanaa
  • United Kingdom (Northern Ireland) · Busulfan Accord, Busulfan Aspen Pharma Trading Limited
  • Greece · Busulfan Bioars
  • Croatia · Busulfan Pliva
  • Hungary · Busulfan Accord, Busulfan Teva
  • Ireland · Myleran
  • Iceland · Busulfan Fresenius Kabi, Myleran
  • Italy · Busulfan Accord, Busulfan Tillomed
  • Liechtenstein · Busulfan Fresenius Kabi
  • Lithuania · Myleran
  • Luxembourg · Myleran
  • Norway · Busulfan Fresenius Kabi
  • Poland · Busulfan Accord, Busulfan Zentiva
  • Portugal · Bussulfano Accord, Myleran
  • Romania · Busulfan Accord, Myleran
  • Sweden · Busulfan Zentiva, Myleran
  • Slovakia · Myleran

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ba4812c3-226a-4618-86a5-c882b068ab16
GET /v1/drugs/ba4812c3-226a-4618-86a5-c882b068ab16?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentraat voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h120583_smpc.pdf",
  "strength": null,
  "atc_label": "Busulfan",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg133339",
  "excipients": [
    "CITROENZUUR 0-WATER (E 330)",
    "DIMETHYLACETAMIDE",
    "MACROGOL 400"
  ],
  "substances": [
    "BUSULFAN"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h133339.pdf",
  "authorised_at": "2024/10/21",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "133339//120583",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about busulfan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console